М.Г. Кавиладзе

article 2023

Enhanced expression of certain biomarkers as a predictive factor for malignant transformation of atypic lesions in ovarian endometriosis

·doi:10.1016/j.jeud.2023.100029

Patients with ovarian endometriosis (OE) are known to have a 2.5-fold increase in the risk of malignant neoplasms. OE is polymorphic condition histologically subdivided on two forms: “without atypia” and “with atypia”. First form is conside…

article 2023

Evaluation of expression patterns of different nicotinic acetylcholine receptor subunits in ovarian endometriosis in the search for promising new therapeutic targets for endometriosis

·doi:10.20953/1726-1678-2023-5-5-14

Objective. To study and evaluate the expression patterns of different subunits of nicotinic acetylcholine receptors (nAChRs) in reproductive-aged patients with ovarian endometriosis. Patients and methods. This study included 60 patients who…

article 2021

Adenomyosis. What has changed since the advent of ICD-11?

·doi:10.20953/1726-1678-2021-2-117-124

Over the years, it has been discussed that adenomyosis is not merely endometriosis of the uterus, but an independent disease with its inherent pathogenesis and clinical mechanisms. Adenomyosis and endometriosis are distinguished not only by…